• Contact us |
• Site map

• About Xarelto
  • Xarelto: SPC
  • Efficacy
  • Reassuring Safety
  • Convenient Oral Therapy
  • Xarelto in Practice - Q&A
  • Health Economics
  • For the Patient

  

  Examine impressive results for simple, uncomplicated clot prevention
• Clinical Studies
  • Major Orthopaedic Surgery
  • Stroke Prevention in Atrial Fibrillation
  • Medically Ill
  • VTE Treatment
  • Secondary Prevention in Acute Coronary Syndrome

  

  See extensive results for the most studied anticoagulant of its kind
• Targeting Factor Xa
  • The Central Role of Factor Xa
  • The Coagulation Cascade
  • Xarelto - Excellent Efficacy and Convenience with Reassuring Safety

  

  View the direct inhibition of Factor Xa, an active area of research
• Thrombosis Risk
  • When Thrombosis Occurs
  • VTE - A Serious Threat
  • Stroke Prevention in Atrial Fibrillation
  • Acute Coronary Syndrome

  

  Thromboembolic disorders pose life threatening risks to millions of patients
• Resources
  • Publications
  • Xarelto News
  • Benefit Calculator
  • Other Websites of Interest
  • Downloads
  • Events Calendar
  • For the Press

  

  Connect with a world of events devoted to thromboembolic research

• Search

The Coagulation Cascade

---

© 2010, Bayer Schering Pharma AG
This website is intended to provide information to an international audience outside the USA and UK.
Last updated on 9th March 2010